Jose Andres Alepuz Guillen, PhD
Postdoctoral Associate
Boston University Chobanian & Avedisian School of Medicine
Medicine




Dr. Alepuz currently a Postdoctoral Researcher in the laboratory of Dr. David A. Harris in the Department of Biochemistry at Boston University School of Medicine. He hold a B.Sc. Biochemistry from Queen Mary University of London, a M.Sc. from King’s College London and a Ph.D. from the School of Molecular Biosciences at the University of Glasgow, where he studied at the Institute for Translational Pharmacology under the guidance of Prof. Andrew B. Tobin and Prof. Graeme Milligan. During his doctoral work, he investigated the potential role of the M1 muscarinic acetylcholine receptor in misfolded protein propagation using primary neuronal cultures. His research at the Harris Lab is focused on Creutzfeldt-Jakob disease and the E200K PrP mutation utilizing iPSC-derived cells and primary neuronal and astrocyte cultures.


Characterization of synaptic abnormalities in iPSC-derived neurons from E200K carriers
03/01/2025 - 02/28/2026 (PI)
Creutzfeldt-Jakob Diseases Foundation, Inc.




Title


Yr Title Project-Sub Proj Pubs

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Website       Copy PMIDs To Clipboard

  1. Ashraf A, Alepuz Guillen JA, Aljuhani M, Hubens C, So PW. Low Cerebrospinal Fluid Levels of Melanotransferrin Are Associated With Conversion of Mild Cognitively Impaired Subjects to Alzheimer's Disease. Front Neurosci. 2019; 13:181. PMID: 30906244
     

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 1 publications over 1 distinct years, with a maximum of 1 publications in 2019

YearPublications
20191

Contact for Mentoring:

Same Department
Search Department